← Health care and life sciences companies

    Adicet Bio: company profile, size and contacts

    adicetbio.comActiveFor profit

    Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

    Employees
    101-250
    Founded
    2014
    Total raised
    $243.6M
    Monthly visits
    1,885

    Company facts

    Website
    adicetbio.com
    Location
    San Francisco Bay Area, Silicon Valley, West Coast, Western US
    Employees
    101-250
    Founded
    2014 (12 years ago)
    Categories
    Biopharma, Biotechnology, Health Care, Medical
    Company type
    For profit
    Listing
    Private
    Industry code (NAICS)
    6211 Offices of physicians; 3254 Pharmaceutical and medicine manufacturing
    Industry code (SIC)
    8000 Health services; 2834 Pharmaceutical preparations

    Founder

    • Aya JakobovitsFounder · Adicet Bio

    Adicet Bio was founded in 2014 by Aya Jakobovits.

    Funding

    Total raised
    $243.6M
    Funding rounds
    5
    Latest round
    Post ipo equity, 2024-01
    Investors
    6
    Lead investors
    1
    Acquisitions made
    1

    Web and app presence

    Monthly website visits
    1,885
    Global traffic rank
    #4,777,966

    How Adicet Bio compares

    • Size: Adicet Bio has more employees than 69% of the 1251 health care and life sciences companies in our directory that report it.
    • Age: Adicet Bio is older than 21% of the 1166 health care and life sciences companies in our directory that report it.
    • Web traffic: Adicet Bio gets more monthly website visits than 49% of the 1233 health care and life sciences companies in our directory that report it.

    1282 health care and life sciences companies are in the directory, 165 of them in the same 101-250 employee range and 43 based in San Francisco Bay Area.

    Growth outlook

    • Trend: Growing

    Adicet Bio may be growing as indicated by several financial activities and market responses. A director from Orbimed Advisors Llc acquired a significant number of shares, specifically 3125000 shares, which could suggest confidence in the company's prospects and stability. Additionally, the company's stock has been given an average rating of 'Moderate Buy' by analysts, reflecting a positive market sentiment towards Adicet Bio. Furthermore, the estimated fair value of the company's stock is reported to be US$5.96 based on a 2 Stage Free Cash Flow to Equity model, which may imply that the current stock price is undervalued, potentially attracting more investors.

    What Adicet Bio says about itself

    “Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases.” adicetbio.com

    Adicet Bio in short

    Founded in 2014, Adicet Bio works in biopharma, biotechnology and health care from San Francisco Bay Area and has 101-250 employees. It has raised $243.6 million over 5 rounds and its website drew about 1,885 visits in the latest month measured.

    Frequently asked questions

    What does Adicet Bio do?
    Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer
    When was Adicet Bio founded?
    Adicet Bio was founded in 2014, so it is about 12 years old.
    How many employees does Adicet Bio have?
    Crunchbase lists Adicet Bio in the 101-250 employee range.
    Where is Adicet Bio based?
    Adicet Bio is listed under San Francisco Bay Area, Silicon Valley, West Coast, Western US.
    Has Adicet Bio raised funding?
    Crunchbase records $243.6M raised across 5 funding rounds, most recently post ipo equity in 2024-01.
    How do I find email addresses at Adicet Bio?
    Search the domain adicetbio.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in Health care and life sciences companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.